126 related articles for article (PubMed ID: 15174910)
1. Plasma homocysteine and restenosis after femoropopliteal angioplasty.
Kovacevic T; Van Der Loo B; Amann-Vesti BR; Rousson V; Koppensteiner R
J Endovasc Ther; 2004 Jun; 11(3):302-9. PubMed ID: 15174910
[TBL] [Abstract][Full Text] [Related]
2. Blood fluidity and outcome after femoropopliteal percutaneous transluminal angioplasty (PTA): role of plasma viscosity and low platelet count in predicting restenosis.
van der Loo B; Kovacevic T; Krieger E; Banyai S; Banyai M; Amann-Vesti BR; Jagacic D; Rousson V; Koppensteiner R
Clin Hemorheol Microcirc; 2005; 32(2):159-68. PubMed ID: 15764824
[TBL] [Abstract][Full Text] [Related]
3. Homocysteine levels, haemostatic risk factors and patency rates after endovascular treatment of the above-knee femoro-popliteal artery.
Laxdal E; Eide GE; Wirsching J; Jenssen GL; Jonung T; Pedersen G; Amundsen SR; Dregelid E; Aune S
Eur J Vasc Endovasc Surg; 2004 Oct; 28(4):410-7. PubMed ID: 15350565
[TBL] [Abstract][Full Text] [Related]
4. [Percutaneous transluminal angioplasty (PTA) in peripheral arterial occlusive disease of the lower extremities].
Minar E; Ahmadi RA; Ehringer H; Marosi L; Czembirek H; Konecny U
Wien Klin Wochenschr; 1986 Jan; 98(2):33-40. PubMed ID: 2938339
[TBL] [Abstract][Full Text] [Related]
5. Cutting balloon versus conventional balloon angioplasty in short femoropopliteal arterial stenoses.
Cotroneo AR; Pascali D; Iezzi R
J Endovasc Ther; 2008 Jun; 15(3):283-91. PubMed ID: 18540701
[TBL] [Abstract][Full Text] [Related]
6. Effects of probucol versus aspirin and versus brachytherapy on restenosis after femoropopliteal angioplasty: the PAB randomized multicenter trial.
Gallino A; Do DD; Alerci M; Baumgartner I; Cozzi L; Segatto JM; Bernier J; Tutta P; Kellner F; Triller J; Schneider E; Amann-Vesti B; Studer G; Jäger K; Aschwanden M; Canevascini R; Jacob AL; Kann R; Greiner R; Mahler F
J Endovasc Ther; 2004 Dec; 11(6):595-604. PubMed ID: 15615549
[TBL] [Abstract][Full Text] [Related]
7. [Results of percutaneous transluminal angioplasty of the femoropopliteal axis. Apropos of a series of 65 consecutive cases].
Glock Y; Joffre F; de Jong Z; Boccalon H; Puel P
Chirurgie; 1985; 111(6):452-6. PubMed ID: 2935375
[No Abstract] [Full Text] [Related]
8. Vascular inflammation and percutaneous transluminal angioplasty of the femoropopliteal artery: association with restenosis.
Schillinger M; Exner M; Mlekusch W; Rumpold H; Ahmadi R; Sabeti S; Haumer M; Wagner O; Minar E
Radiology; 2002 Oct; 225(1):21-6. PubMed ID: 12354979
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive endovascular therapy for femoropopliteal arterial atherosclerotic occlusive disease.
Davies MG; Waldman DL; Pearson TA
J Am Coll Surg; 2005 Aug; 201(2):275-96. PubMed ID: 16038827
[No Abstract] [Full Text] [Related]
10. Plasma tissue factor is a predictor for restenosis after femoropopliteal angioplasty.
Ray B; Chetter IC; Lee HL; Ettelaie C; McCollum PT
Br J Surg; 2007 Sep; 94(9):1092-5. PubMed ID: 17497755
[TBL] [Abstract][Full Text] [Related]
11. Angioplasty treatment for peripheral vascular disease.
Iannone L; Rough R; Ghali M; Rayl KL; Phillips S
Iowa Med; 1996 Sep; 86(7):281-3. PubMed ID: 8854576
[No Abstract] [Full Text] [Related]
12. Percutaneous transluminal angioplasty with or without stenting for femoropopliteal occlusions? A randomized controlled study.
Zdanowski Z; Albrechtsson U; Lundin A; Jonung T; Ribbe E; Thörne J; Norgren L
Int Angiol; 1999 Dec; 18(4):251-5. PubMed ID: 10811511
[TBL] [Abstract][Full Text] [Related]
13. Long-segment arterial occlusion: percutaneous transluminal angioplasty.
Lu CT; Zarins CK; Yang CF; Sottiurai V
AJR Am J Roentgenol; 1982 Jan; 138(1):119-22. PubMed ID: 6459724
[TBL] [Abstract][Full Text] [Related]
14. [The place of percutaneous transluminal angioplasty in the management of obliterative vascular diseases of the lower extremities. Femoro-popliteal arterial angioplasty].
Fazekas P; Horváth T; Frey J; Erdélyi B
Orv Hetil; 1993 Nov; 134(45):2481-5. PubMed ID: 8247514
[TBL] [Abstract][Full Text] [Related]
15. [Percutaneous transluminal angioplasty (PTA) by the Gruntzig balloon catheter in arterial occlusive diseases of the limbs].
Nakayama Y; Uraguchi K; Ooishi K; Koga M; Tashiro T
Rinsho Kyobu Geka; 1982 Nov; 2(6):785-94. PubMed ID: 6220457
[No Abstract] [Full Text] [Related]
16. [Percutaneous transluminal atherectomy of the femoropopliteal arteries. Technic, indications, results after 6 months].
Maquin P; Railhac N; Brunet M; Fajadet P; Lefebvre D; Bossavy JP; Railhac JJ
Ann Radiol (Paris); 1989; 32(5):383-9. PubMed ID: 2532873
[TBL] [Abstract][Full Text] [Related]
17. Balloon angioplasty of the femoro-popliteal segment: follow up results from southern India.
Unni NM; Mandalam KR; Rao VR; Gupta AK; Joseph S; Rao AS; Unnikrishnan M; Neelakandhan KS
Natl Med J India; 1995; 8(3):105-13. PubMed ID: 7780349
[TBL] [Abstract][Full Text] [Related]
18. Femoropopliteal angioplasty. Factors influencing long-term success.
Capek P; McLean GK; Berkowitz HD
Circulation; 1991 Feb; 83(2 Suppl):I70-80. PubMed ID: 1825050
[TBL] [Abstract][Full Text] [Related]
19. Percutaneous transluminal angioplasty. Therapy for vascular occlusive disease of the lower extremities.
Sinning MA; Dixon GD; Pinkerton JA
J Kans Med Soc; 1983 Jun; 84(6):331-4, 355. PubMed ID: 6223966
[No Abstract] [Full Text] [Related]
20. Percutaneous viabahn-assisted subintimal recanalization (VASIR) for severe femoropopliteal occlusive disease.
Verta MJ; Schneider JR; Alonzo M; Hahn D
Acta Chir Belg; 2007; 107(2):181-6. PubMed ID: 17515268
[No Abstract] [Full Text] [Related]
[Next] [New Search]
